1. News and Innovations.
- Subjects
- *
GLUCOSAMINE , *RNA physiology , *CAREGIVER education , *PALLIATIVE treatment laws , *FAMILIES & psychology , *DRUG laws , *DULOXETINE , *DRUG control , *PSYCHOLOGICAL adaptation , *ELDER care , *ANALGESICS , *ANTICONVULSANTS , *BACKACHE , *BUPRENORPHINE , *CANCER patients , *CEREBROVASCULAR disease , *HOSPICE care , *CHRONIC pain , *MEDICAL protocols , *MENINGITIS , *NARCOTICS , *NONSTEROIDAL anti-inflammatory agents , *NURSING education , *PALLIATIVE treatment , *PHARMACEUTICAL industry , *SPECIAL days , *TRANSDERMAL medication , *WORLD Wide Web , *INFORMATION resources , *DRUG approval , *SOCIAL attitudes , *DRUG dosage , *GENETICS , *THERAPEUTICS - Abstract
The article presents medical news briefs. A U.S. Food and Drug Administration panel voted on July 23, 2010 against the opioid Risk Evaluation and Mitigation Strategies. The hospice Education Network announced in June of 2010 they were adding nine End-of-Life Nursing Education Geriatric Palliative Care modules to their course catalog. A randomized controlled trial reported glucosamine had little effect on patients with degenerative lumbar osteoarthritis and chronic low back pain.
- Published
- 2010
- Full Text
- View/download PDF